These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36524012)

  • 1. Amide-functionalized 1,2,4-Triazol-5-amines as Covalent Inhibitors of Blood Coagulation Factor XIIa and Thrombin.
    Imberg L; Platte S; Erbacher C; Daniliuc CG; Kalinina SA; Dörner W; Poso A; Karst U; Kalinin DV
    ACS Pharmacol Transl Sci; 2022 Dec; 5(12):1318-1347. PubMed ID: 36524012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors.
    Platte S; Korff M; Imberg L; Balicioglu I; Erbacher C; Will JM; Daniliuc CG; Karst U; Kalinin DV
    ChemMedChem; 2021 Dec; 16(24):3672-3690. PubMed ID: 34278727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated 1
    Korff M; Imberg L; Will JM; Bückreiß N; Kalinina SA; Wenzel BM; Kastner GA; Daniliuc CG; Barth M; Ovsepyan RA; Butov KR; Humpf HU; Lehr M; Panteleev MA; Poso A; Karst U; Steinmetzer T; Bendas G; Kalinin DV
    J Med Chem; 2020 Nov; 63(21):13159-13186. PubMed ID: 33089691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
    Xu Y; Cai TQ; Castriota G; Zhou Y; Hoos L; Jochnowitz N; Loewrigkeit C; Cook JA; Wickham A; Metzger JM; Ogletree ML; Seiffert DA; Chen Z
    Thromb Haemost; 2014 Apr; 111(4):694-704. PubMed ID: 24336918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazol-1-yl Benzamides Promote Anticoagulant Activity
    Al-Horani RA; Afosah DK; Mottamal M
    Cardiovasc Hematol Agents Med Chem; 2023; 21(2):108-119. PubMed ID: 36321236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazole-Based Thrombin Inhibitors with a Serine-Trapping Mechanism of Action: Synthesis and Biological Activity.
    Dunker C; Imberg L; Siutkina AI; Erbacher C; Daniliuc CG; Karst U; Kalinin DV
    Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An automated analysis method enabling the screening of covalent thrombin and factor XIIa inhibitors via liquid chromatography-mass spectrometry.
    Erbacher C; Athmer M; Kröger E; Dahrendorf L; Imberg L; Kalinin DV; Karst U
    Drug Test Anal; 2024 Mar; 16(3):314-322. PubMed ID: 37482900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors.
    Bouckaert C; Serra S; Rondelet G; Dolušić E; Wouters J; Dogné JM; Frédérick R; Pochet L
    Eur J Med Chem; 2016 Mar; 110():181-94. PubMed ID: 26827162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Infestin-4 Mutants with Increased Selectivity against Factor XIIa.
    Kolyadko VN; Lushchekina SV; Vuimo TA; Surov SS; Ovsepyan RA; Korneeva VA; Vorobiev II; Orlova NA; Minakhin L; Kuznedelov K; Severinov KV; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(12):e0144940. PubMed ID: 26670620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.
    Konings J; Govers-Riemslag JW; Philippou H; Mutch NJ; Borissoff JI; Allan P; Mohan S; Tans G; Ten Cate H; Ariëns RA
    Blood; 2011 Oct; 118(14):3942-51. PubMed ID: 21828145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Docking and Molecular Dynamics Simulations towards the Identification of Potential Inhibitors against Human Coagulation Factor XIIa.
    Xu D; Xue G; Peng B; Feng Z; Lu H; Gong L
    Comput Math Methods Med; 2020; 2020():2852051. PubMed ID: 32549905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood.
    Hansson KM; Nielsen S; Elg M; Deinum J
    J Thromb Haemost; 2014 Oct; 12(10):1678-86. PubMed ID: 25142753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
    Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
    J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals.
    Barbieri CM; Wang X; Wu W; Zhou X; Ogawa AM; O'Neill K; Chu D; Castriota G; Seiffert DA; Gutstein DE; Chen Z
    J Pharmacol Exp Ther; 2017 Mar; 360(3):466-475. PubMed ID: 28035006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of Some New 2,5-Substituted 1-Ethyl-1H-benzoimidazole Fluorinated Derivatives as Direct Thrombin Inhibitors.
    Li M; Ren Y
    Arch Pharm (Weinheim); 2015 May; 348(5):353-65. PubMed ID: 25824648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Cyclic Peptide Inhibitors of FXIIa Discovered by mRNA Display with Genetic Code Reprogramming.
    Ford DJ; Duggan NM; Fry SE; Ripoll-Rozada J; Agten SM; Liu W; Corcilius L; Hackeng TM; van Oerle R; Spronk HMH; Ashhurst AS; Mini Sasi V; Kaczmarski JA; Jackson CJ; Pereira PJB; Passioura T; Suga H; Payne RJ
    J Med Chem; 2021 Jun; 64(11):7853-7876. PubMed ID: 34044534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
    Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
    Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.